sequence under fasting conditions ,A randomized&#44

An open-labeled, randomized, single-dose, 2-period, 2-treatment, 2-way crossover bioequivalence study of Valsartan/Amlodipine 160/10 mg in male and female subjects under fasting conditions.

Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two treatment and two-sequence of Azithromycin Powder for Oral Suspension (200mg/5ml) relative to ZITHROMAX (Original Azithromycin Powder for Oral Suspension (200mg/5ml) in healthy Thai volunteers under fasting condition

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Levocetirizine 5 mg tablets relative to Xyzal® 5 mg tablets in healthy Thai volunteers under fasting condition.

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rasagiline Tablets (1 mg) relative to Originator Rasagiline (1 mg) in healthy Thai volunteers under fasting condition.

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Ticagrelor Tablets (90 mg) relative to Originator Ticagrelor Tablets (90 mg) in healthy Thai volunteers under fasting condition.

Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of 2 tablets of Levonorgestrel Tablets (0.75 mg) relative to 2 tables of POSTINOR® in healthy Thai female volunteers under fasting condition